Strategy
Patent dispute settlement by Arbitration
Abstract
Introduction Intellectual Property Rights is one of most important property of almost all the domain globally New technologies in the field of life sciences have resulted in the increase of number of patent applications filed worldwide Exploitation protection and enforcement of patent rights at the international level are very crucial for all th...
Molecular Medicines and Diagnosis
The patient and physician relationship involves a number of steps such as the advice on hygiene maintenance chronic or nonchronicinfectious disease diagnosis measures to limit the spread of disease continuous requirement of diagnostic tools techniques and diagnostic centres pharmacy disease monitoring process and data management obedience of statut...
Key Elements of the FDA\'s Draft Biosimilars Guidance
On th February The US FDA announced the first three of the eagerlyawaited draft guidance documents for biosimilars followon biologics Biosimilars Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of Scientific Considerations in Demonstrating Biosimilarity to a Reference Product Quality C...
Pharmacoeconomics Requirements in Asia
Mandatory requirements for companies to include cost effectiveness analysis as part of reimbursement submissions are in place across much of Europe Canada and Australia Over the next few years Korea is expected follow the lead of these countries and focus on concepts such as assessment and efficiency Economic Evaluation in Korea In early the...
Non-Clinical Drug Development in Asia
A literature review and landscape assessment
Nonclinical development costs activities including drug discovery biology research chemistry research preclinical continues to account for a large percentage of overall drug Research and Development RD costs The Pharmaceutical Research and Manufacturers of America PhRMA estimated that in US billion or per cent of overall RD costs are attributed t...
Innovative Partnership Model
Translating research into products and best practices for spinal cord injury
Spinal Cord Injury SCI is one of the greatest survivable catastrophes experienced by a human being Regardless of cause or age at injury SCI has a devastating impact on an injured persons health and wellbeing and far reaching consequences for individuals their families and the healthcare system There is cur
Open Innovative Partnerships
A working model for the future of drug discovery and development
The pharmaceutical industrys long successful strategy of placing big bets on a few molecules promoting them heavily and turning them into blockbusters worked well for many years but its Research and Development RD productivity has now plummeted and the environment is changing According to the Pharmaceutical Research and Manufacturers of America PhR...
A New Phase of Outsourcing
In seeking cost savings pharmaceutical companies have looked at two options offshoring and outsourcing The former which involves setting up a companys own operations in a lowcost base country is now being replaced with the latter as service providers especially in India prove themselves to be worthy partners India in particular has been gearing...
Raising the Bar for Clinical Research
Reliance Clinical Research Services RCRS a fullservice contract clinical research organisation is a business initiative of the bn Reliance Group which meets the contract clinical research service needs of pharmaceutical biotechnology and medical device companies at a global level Its range of services include project management protocol design clin...
Tracking CRO Growth
Falling research and development productivity allied with the failure to bring new drugs to the market has resulted in declining financial performance for many pharmaceutical companies over the past five years One driver to increase RD productivity is to make better decisions on which potential drugs are commercially viable and which drugs could be...
